Literature DB >> 8547057

Pityriasis rubra pilaris and human immunodeficiency virus infection.

E S Miralles1, M Núñez, M E De Las Heras, B Pérez, R Moreno, A Ledo.   

Abstract

Recently, the occurrence of pityriasis rubra pilaris (PRP) has been reported in patients with HIV infection. It presents different clinical features, and has a poorer prognosis, than the classical adult type of PRP. We report the occurrence of severe PRP in an HIV-infected patient, and review the previously reported cases of this association. We propose the designation of a new category of PRP (type 6), characterized by the presence of HIV infection, usually without immunosuppression, a poor prognosis and response to treatment, and the development of nodulocystic and lichen spinulosus lesions.

Entities:  

Mesh:

Year:  1995        PMID: 8547057     DOI: 10.1111/j.1365-2133.1995.tb06939.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Familial pityriasis rubra pilaris is caused by mutations in CARD14.

Authors:  Dana Fuchs-Telem; Ofer Sarig; Maurice A M van Steensel; Ofer Isakov; Shirli Israeli; Janna Nousbeck; Katharina Richard; Veronique Winnepenninckx; Marigje Vernooij; Noam Shomron; Jouni Uitto; Philip Fleckman; Gabriele Richard; Eli Sprecher
Journal:  Am J Hum Genet       Date:  2012-06-14       Impact factor: 11.025

2.  Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial.

Authors:  Dylan Haynes; Jennifer L Strunck; Christina A Topham; Alex G Ortega-Loayza; Gail Kent; Pamela B Cassidy; Ronghua Hu; Keith Choate; Zhiping Wang; Yuangang Liu; Teri M Greiling
Journal:  JAMA Dermatol       Date:  2020-06-01       Impact factor: 10.282

3.  Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris.

Authors:  Alessandro Di Stefani; Marco Galluzzo; Marina Talamonti; Andrea Chiricozzi; Antonio Costanzo; Sergio Chimenti
Journal:  J Dermatol Case Rep       Date:  2013-03-30

4.  Systemic sclerosis in a patient with pityriasis rubra pilaris.

Authors:  Faten Frikha; Makram Frigui; Hatem Masmoudi; Hamida Turki; Zouhir Bahloul
Journal:  Pan Afr Med J       Date:  2010-08-09

Review 5.  Management of refractory pityriasis rubra pilaris: challenges and solutions.

Authors:  Gaia Moretta; Erika V De Luca; Alessandro Di Stefani
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-11-09

6.  Atypical Adult-Onset Pityriasis Rubra Pilaris in an HIV-Positive Adult Male.

Authors:  Pragya Ashok Nair; Niral Sheth
Journal:  Indian J Dermatol       Date:  2018 Nov-Dec       Impact factor: 1.494

7.  Erythroderma in the course of pityriasis rubra pilaris in a 7-year-old female.

Authors:  Agata D Kłosowicz; Katarzyna Kaleta; Anna Ryczek; Natalia Juśko; Monika Kapińska-Mrowiecka
Journal:  Postepy Dermatol Alergol       Date:  2019-08-30       Impact factor: 1.837

8.  Pityriasis Rubra Pilar and hypothyroidism.

Authors:  Aline Martinez Franzotti; Juliana Centofanti Dentello Avelar; Thaís Abrão Cardoso; Mario Cesar Pires; Maria do Rosário Vidigal
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

9.  Successful treatment of type I pityriasis rubra pilaris with ixekizumab.

Authors:  Mark D Heibel; Haley D Heibel
Journal:  JAAD Case Rep       Date:  2018-09-14

Review 10.  Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease.

Authors:  Laura Israel; Mark Mellett
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.